295 related articles for article (PubMed ID: 18550701)
21. Recombinant human erythropoietin stimulates melanoma tumor growth through activation of initiation factor eIF4E.
Julius A; Desai A; Yung RL
Oncotarget; 2017 May; 8(18):30317-30327. PubMed ID: 28415825
[TBL] [Abstract][Full Text] [Related]
22. Conditional expression of MAP kinase phosphatase-2 protects against genotoxic stress-induced apoptosis by binding and selective dephosphorylation of nuclear activated c-jun N-terminal kinase.
Cadalbert L; Sloss CM; Cameron P; Plevin R
Cell Signal; 2005 Oct; 17(10):1254-64. PubMed ID: 16038800
[TBL] [Abstract][Full Text] [Related]
23. Activation of NAG-1 via JNK signaling revealed an isochaihulactone-triggered cell death in human LNCaP prostate cancer cells.
Chiu SC; Wang MJ; Yang HH; Chen SP; Huang SY; Chen YL; Lin SZ; Harn HJ; Pang CY
BMC Cancer; 2011 Apr; 11():146. PubMed ID: 21504622
[TBL] [Abstract][Full Text] [Related]
24. Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative.
Chamorro ME; Wenker SD; Vota DM; Vittori DC; Nesse AB
Biochim Biophys Acta; 2013 Aug; 1833(8):1960-8. PubMed ID: 23602701
[TBL] [Abstract][Full Text] [Related]
25. RACK1 mediates activation of JNK by protein kinase C [corrected].
López-Bergami P; Habelhah H; Bhoumik A; Zhang W; Wang LH; Ronai Z
Mol Cell; 2005 Aug; 19(3):309-20. PubMed ID: 16061178
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
[TBL] [Abstract][Full Text] [Related]
27. ERK1 Directly Interacts With JNK1 Leading to Regulation of JNK1/c-Jun Activity and Cell Transformation.
Kang BS; Hwang YJ; Dong Z
J Cell Biochem; 2017 Aug; 118(8):2357-2370. PubMed ID: 28106280
[TBL] [Abstract][Full Text] [Related]
28. c-Jun N-terminal kinase activity supports multiple phases of 3D-mammary epithelial acinus formation.
McNally S; McArdle E; Gilligan E; Napoletano S; Gajewska M; Bergin O; McCarthy S; Whyte J; Bianchi A; Stack J; Martin F
Int J Dev Biol; 2011; 55(7-9):731-44. PubMed ID: 22161830
[TBL] [Abstract][Full Text] [Related]
29. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
Lin CW; Yang LY; Shen SC; Chen YC
J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of extracellular signal-regulated protein kinase 1 and Jun N-terminal kinase 1 by Ca2+ and protein kinase C in endothelin-stimulated Rat-1 cells.
Cadwallader K; Beltman J; McCormick F; Cook S
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):795-804. PubMed ID: 9032468
[TBL] [Abstract][Full Text] [Related]
31. No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A
Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289
[TBL] [Abstract][Full Text] [Related]
32. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X
Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
[TBL] [Abstract][Full Text] [Related]
33. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis.
Sui X; Krantz SB; You M; Zhao Z
Blood; 1998 Aug; 92(4):1142-9. PubMed ID: 9694701
[TBL] [Abstract][Full Text] [Related]
34. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
[TBL] [Abstract][Full Text] [Related]
35. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury.
Li X; Gonias SL; Campana WM
Glia; 2005 Sep; 51(4):254-65. PubMed ID: 15812815
[TBL] [Abstract][Full Text] [Related]
36. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation.
Nagata Y; Takahashi N; Davis RJ; Todokoro K
Blood; 1998 Sep; 92(6):1859-69. PubMed ID: 9731042
[TBL] [Abstract][Full Text] [Related]
37. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH
Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest.
Kuntzen C; Sonuc N; De Toni EN; Opelz C; Mucha SR; Gerbes AL; Eichhorst ST
Cancer Res; 2005 Aug; 65(15):6780-8. PubMed ID: 16061660
[TBL] [Abstract][Full Text] [Related]
39. A new model to evaluate Raf signaling in hematopoietic cells.
Okuda K
Int J Oncol; 2013 Sep; 43(3):903-10. PubMed ID: 23820731
[TBL] [Abstract][Full Text] [Related]
40. Indoxyl sulfate counteracts endothelial effects of erythropoietin through suppression of Akt phosphorylation.
Adelibieke Y; Shimizu H; Saito S; Mironova R; Niwa T
Circ J; 2013; 77(5):1326-36. PubMed ID: 23337206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
